BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21038102)

  • 1. Evidence of altered cardiac electrophysiology following prolonged androgenic anabolic steroid use.
    Sculthorpe N; Grace F; Jones P; Davies B
    Cardiovasc Toxicol; 2010 Dec; 10(4):239-43. PubMed ID: 21038102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cardiac repolarization in anabolic androgenic steroid users carrying out submaximal exercise testing.
    Maior AS; Menezes P; Pedrosa RC; Carvalho DP; Soares PP; Nascimento JH
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1129-33. PubMed ID: 20880189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac autonomic dysfunction in anabolic steroid users.
    Maior AS; Carvalho AR; Marques-Neto SR; Menezes P; Soares PP; Nascimento JH
    Scand J Med Sci Sports; 2013 Oct; 23(5):548-55. PubMed ID: 22257181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and stratification of the future cardiovascular arrhythmic events: signal averaged electrocardiography versus ejection fraction.
    Pandey AK; Das A; Singwala AK; Bhatt KN
    Indian J Physiol Pharmacol; 2010; 54(2):123-32. PubMed ID: 21090529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.
    Karila T; Hovatta O; Seppälä T
    Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anabolic androgenic steroids on heart rate recovery index and electrocardiographic parameters in male bodybuilders.
    Baytugan NZ; Kandemir HÇ
    J Electrocardiol; 2024; 84():95-99. PubMed ID: 38579637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings.
    Far HR; Ågren G; Thiblin I
    Cardiovasc Pathol; 2012; 21(4):312-6. PubMed ID: 22104006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal signal-averaged electrocardiogram (SAECG) in obesity.
    Lalani AP; Kanna B; John J; Ferrick KJ; Huber MS; Shapiro LE
    Obes Res; 2000 Jan; 8(1):20-8. PubMed ID: 10678255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal-averaged ECG in patients after anthracycline therapy for childhood cancer.
    Mladosievicová B; Foltinová A; Bernadic M; Hubka P; Petrásová H; Hulín I
    Neoplasma; 1998; 45(1):40-5. PubMed ID: 9605001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
    Hartgens F; Cheriex EC; Kuipers H
    Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of late potentials in high frequency signal-averaged electrocardiography and arrhythmias in long-term ECG in healthy probands].
    Buerschaper M; Gonska BD; Bethge KP
    Z Kardiol; 1991 Aug; 80(8):516-22. PubMed ID: 1719709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Signal-averaged electrocardiograms in young athletes--sudden death during exercise].
    Moroe K; Hiroki T
    Nihon Rinsho; 1995 Feb; 53(2):477-82. PubMed ID: 7699876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenic anabolic steroids also impair right ventricular function.
    Kasikcioglu E; Oflaz H; Umman B; Bugra Z
    Int J Cardiol; 2009 May; 134(1):123-5. PubMed ID: 18272244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criminality among individuals testing positive for the presence of anabolic androgenic steroids.
    Klötz F; Garle M; Granath F; Thiblin I
    Arch Gen Psychiatry; 2006 Nov; 63(11):1274-9. PubMed ID: 17088508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.
    Montisci M; El Mazloum R; Cecchetto G; Terranova C; Ferrara SD; Thiene G; Basso C
    Forensic Sci Int; 2012 Apr; 217(1-3):e13-8. PubMed ID: 22047750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users.
    Graham MR; Baker JS; Evans P; Kicman A; Cowan D; Hullin D; Davies B
    Growth Horm IGF Res; 2007 Jun; 17(3):201-9. PubMed ID: 17324600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study.
    Di Bello V; Giorgi D; Bianchi M; Bertini A; Caputo MT; Valenti G; Furioso O; Alessandri L; Paterni M; Giusti C
    Med Sci Sports Exerc; 1999 Apr; 31(4):514-21. PubMed ID: 10211845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.